{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T07:30:44Z","timestamp":1791099044148,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2011,7,7]],"date-time":"2011-07-07T00:00:00Z","timestamp":1309996800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1007\/s10585-011-9402-z","type":"journal-article","created":{"date-parts":[[2011,7,6]],"date-time":"2011-07-06T15:09:51Z","timestamp":1309964991000},"page":"701-712","source":"Crossref","is-referenced-by-count":29,"title":["The dual role of TLR3 in metastatic cell line"],"prefix":"10.1007","volume":"28","author":[{"given":"Tanja","family":"Matijevic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasminka","family":"Pavelic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,7,7]]},"reference":[{"key":"9402_CR1","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.1158\/1535-7163.MCT-08-0582","volume":"7","author":"Y Goto","year":"2008","unstructured":"Goto Y, Arigami T, Kitago M et al (2008) Activation of toll-like receptors 2, 3, and 4 on human melanoma cells induces inflammatory factors. Mol Cancer Ther 7:3642\u20133653","journal-title":"Mol Cancer Ther"},{"key":"9402_CR2","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1016\/j.molimm.2007.01.022","volume":"44","author":"W He","year":"2007","unstructured":"He W, Liu Q, Wang L et al (2007) TLR4 signaling promotes immune escape of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistance. Mol Immunol 44:2850\u20132859","journal-title":"Mol Immunol"},{"key":"9402_CR3","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/pros.20562","volume":"67","author":"JM Ilvesaro","year":"2007","unstructured":"Ilvesaro JM, Merrell MA, Swain TM et al (2007) Toll like receptor-9 agonists stimulate prostate cancer invasion in vitro. Prostate 67:774\u2013781","journal-title":"Prostate"},{"key":"9402_CR4","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1525-1438.2007.01008.x","volume":"18","author":"WY Kim","year":"2008","unstructured":"Kim WY, Lee JW, Choi JJ et al (2008) Increased expression of toll-like receptor 5 during progression of cervical neoplasia. Int J Gynecol Cancer 18:300\u2013305","journal-title":"Int J Gynecol Cancer"},{"key":"9402_CR5","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s00262-008-0650-y","volume":"58","author":"M Zhou","year":"2009","unstructured":"Zhou M, McFarland-Mancini MM, Funk HM et al (2009) Toll-like receptor expression in normal ovary and ovarian tumors. Cancer Immunol Immunother 58:1375\u20131385","journal-title":"Cancer Immunol Immunother"},{"key":"9402_CR6","first-page":"209","volume":"21","author":"R Pries","year":"2008","unstructured":"Pries R, Hogrefe L, Xie L et al (2008) Induction of c-Myc-dependent cell proliferation through toll-like receptor 3 in head and neck cancer. Int J Mol Med 21:209\u2013215","journal-title":"Int J Mol Med"},{"key":"9402_CR7","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.bbrc.2009.01.009","volume":"379","author":"W Xie","year":"2009","unstructured":"Xie W, Wang Y, Huang Y et al (2009) Toll-like receptor 2 mediates invasion via activating NF-kappaB in MDA-MB-231 breast cancer cells. Biochem Biophys Res Commun 379:1027\u20131032","journal-title":"Biochem Biophys Res Commun"},{"key":"9402_CR8","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1158\/0008-5472.CAN-05-3948","volume":"66","author":"MG Kelly","year":"2006","unstructured":"Kelly MG, Alvero AB, Chen R et al (2006) TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer. Cancer Res 66:3859\u20133868","journal-title":"Cancer Res"},{"key":"9402_CR9","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1158\/0008-5472.CAN-06-4067","volume":"67","author":"B Huang","year":"2007","unstructured":"Huang B, Zhao J, Shen S et al (2007) Listeria monocytogenes promotes tumor growth via tumor cell toll-like receptor 2 signaling. Cancer Res 67:4346\u20134352","journal-title":"Cancer Res"},{"key":"9402_CR10","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1016\/j.vaccine.2009.01.071","volume":"27","author":"B Jasani","year":"2009","unstructured":"Jasani B, Navabi H, Adams M (2009) Ampligen: a potential toll-like 3 receptor adjuvant for immunotherapy of cancer. Vaccine 27:3401\u20133404","journal-title":"Vaccine"},{"key":"9402_CR11","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.4049\/jimmunol.176.8.4894","volume":"176","author":"B Salaun","year":"2006","unstructured":"Salaun B, Coste I, Rissoan MC et al (2006) TLR3 can directly trigger apoptosis in human cancer cells. J Immunol 176:4894\u20134901","journal-title":"J Immunol"},{"key":"9402_CR12","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1158\/1078-0432.CCR-07-0274","volume":"13","author":"B Salaun","year":"2007","unstructured":"Salaun B, Lebecque S, Matikainen S et al (2007) Toll-like receptor 3 expressed by melanoma cells as a target for therapy? Clin Cancer Res 13:4565\u20134574","journal-title":"Clin Cancer Res"},{"key":"9402_CR13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2407-8-12","volume":"8","author":"Q Jiang","year":"2008","unstructured":"Jiang Q, Wei H, Tian Z (2008) Poly I:C enhances cycloheximide-induced apoptosis of tumor cells through TLR3 pathway. BMC Cancer 8:12","journal-title":"BMC Cancer"},{"key":"9402_CR14","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1365-3083.2009.02262.x","volume":"70","author":"T Matijevic","year":"2009","unstructured":"Matijevic T, Marjanovic M, Pavelic J (2009) Functionally active toll-like receptor 3 on human primary and metastatic cancer cells. Scand J Immunol 70:18\u201324","journal-title":"Scand J Immunol"},{"key":"9402_CR15","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00394-009-0056-4","volume":"49","author":"Y Kishimoto","year":"2010","unstructured":"Kishimoto Y, Tani M, Uto-Kondo H et al (2010) Astaxanthin suppresses scavenger receptor expression and matrix metalloproteinase activity in macrophages. Eur J Nutr 49:119\u2013126","journal-title":"Eur J Nutr"},{"key":"9402_CR16","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.toxlet.2007.02.014","volume":"170","author":"NS Nagaraj","year":"2007","unstructured":"Nagaraj NS, Zacharias W (2007) Cigarette smoke condensate increases cathepsin-mediated invasiveness of oral carcinoma cells. Toxicol Lett 170:134\u2013145","journal-title":"Toxicol Lett"},{"key":"9402_CR17","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/j.1745-7270.2006.00240.x","volume":"38","author":"T Katono","year":"2006","unstructured":"Katono T, Kawato T, Tanabe N et al (2006) Nicotine treatment induces expression of matrix metalloproteinases in human osteoblastic Saos-2 cells. Acta Biochim Biophys Sin 38:874\u2013882","journal-title":"Acta Biochim Biophys Sin"},{"key":"9402_CR18","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1349-7006.2008.01062.x","volume":"100","author":"S Peng","year":"2009","unstructured":"Peng S, Geng J, Sun R et al (2009) Polyinosinic-polycytidylic acid liposome induces human hepatoma cells apoptosis which correlates to the up-regulation of RIG-I like receptors. Cancer Sci 100:529\u2013536","journal-title":"Cancer Sci"},{"key":"9402_CR19","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.bbagrm.2008.04.006","volume":"1779","author":"J Jura","year":"2008","unstructured":"Jura J, Wegrzyn P, Korostynski M et al (2008) Identification of interleukin-1 and interleukin-6-responsive genes in human monocyte-derived macrophages using microarrays. Biochim Biophys Acta 1779:383\u2013389","journal-title":"Biochim Biophys Acta"},{"key":"9402_CR20","doi-asserted-by":"crossref","first-page":"8736","DOI":"10.1158\/0008-5472.CAN-07-1617","volume":"67","author":"J Harper","year":"2007","unstructured":"Harper J, Yan L, Loureiro RM et al (2007) Repression of vascular endothelial growth factor expression by the zinc finger transcription factor ZNF24. Cancer Res 67:8736\u20138741","journal-title":"Cancer Res"},{"key":"9402_CR21","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00262-010-0931-0","volume":"60","author":"S Gonzalez-Reyes","year":"2011","unstructured":"Gonzalez-Reyes S, Fernandez JM, Gonzalez LO et al (2011) Study of TLR3, TLR4, and TLR9 in prostate carcinomas and their association with biochemical recurrence. Cancer Immunol Immunother 60:217\u2013226","journal-title":"Cancer Immunol Immunother"},{"key":"9402_CR22","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1186\/1471-2407-10-665","volume":"10","author":"S Gonzalez-Reyes","year":"2010","unstructured":"Gonzalez-Reyes S, Marin L, Gonzalez L et al (2010) Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis. BMC Cancer 10:665","journal-title":"BMC Cancer"},{"key":"9402_CR23","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1038\/jid.2009.130","volume":"129","author":"P Zigrino","year":"2009","unstructured":"Zigrino P, Kuhn I, Bauerle T et al (2009) Stromal expression of MMP-13 is required for melanoma invasion and metastasis. J Invest Dermatol 129:2686\u20132693","journal-title":"J Invest Dermatol"},{"key":"9402_CR24","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1349-7006.2009.01419.x","volume":"101","author":"M Iwatsuki","year":"2010","unstructured":"Iwatsuki M, Mimori K, Yokobori T et al (2010) Epithelial-mesenchymal transition in cancer development and its clinical significance. Cancer Sci 101:293\u2013299","journal-title":"Cancer Sci"},{"key":"9402_CR25","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1007\/s00018-008-7573-9","volume":"65","author":"CH Tang","year":"2008","unstructured":"Tang CH, Wei Y (2008) The urokinase receptor and integrins in cancer progression. Cell Mol Life Sci 65:1916\u20131932","journal-title":"Cell Mol Life Sci"},{"key":"9402_CR26","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s000180050497","volume":"57","author":"PA Andreasen","year":"2000","unstructured":"Andreasen PA, Egelund R, Petersen HH (2000) The plasminogen activation system in tumor growth invasion and metastasis. Cell Mol Life Sci 57:25\u201340","journal-title":"Cell Mol Life Sci"},{"key":"9402_CR27","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1023\/A:1015539612576","volume":"20","author":"S Sheng","year":"2001","unstructured":"Sheng S (2001) The urokinase-type plasminogen activator system in prostate cancer metastasis. Cancer Metastasis Rev 20:287\u2013296","journal-title":"Cancer Metastasis Rev"},{"key":"9402_CR28","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.semcancer.2005.04.004","volume":"15","author":"M Lechner","year":"2005","unstructured":"Lechner M, Lirk P, Rieder J (2005) Inducible nitric oxide synthase (iNOS) in tumor biology: the two sides of the same coin. Semin Cancer Biol 15:277\u2013289","journal-title":"Semin Cancer Biol"},{"key":"9402_CR29","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0027-5107(99)00006-8","volume":"424","author":"S Burney","year":"1999","unstructured":"Burney S, Caulfield JL, Niles JC et al (1999) The chemistry of DNA damage from nitric oxide and peroxynitrite. Mutat Res 424:37\u201349","journal-title":"Mutat Res"},{"key":"9402_CR30","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/sj.onc.1201201","volume":"15","author":"K Chin","year":"1997","unstructured":"Chin K, Kurashima Y, Ogura T et al (1997) Induction of vascular endothelial growth factor by nitric oxide in human glioblastoma and hepatocellular carcinoma cells. Oncogene 15:437\u2013442","journal-title":"Oncogene"},{"key":"9402_CR31","doi-asserted-by":"crossref","first-page":"E120","DOI":"10.1161\/01.ATV.20.12.e120","volume":"20","author":"F Tronc","year":"2000","unstructured":"Tronc F, Mallat Z, Lehoux S et al (2000) Role of matrix metalloproteinases in blood flow-induced arterial enlargement: interaction with NO. Arterioscler Thromb Vasc Biol 20:E120\u2013E126","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"9402_CR32","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/jlb.63.6.732","volume":"63","author":"M Spiecker","year":"1998","unstructured":"Spiecker M, Darius H, Kaboth K et al (1998) Differential regulation of endothelial cell adhesion molecule expression by nitric oxide donors and antioxidants. J Leukoc Biol 63:732\u2013739","journal-title":"J Leukoc Biol"},{"key":"9402_CR33","first-page":"611","volume":"9","author":"S Gansauge","year":"1998","unstructured":"Gansauge S, Nussler AK, Beger HG et al (1998) Nitric oxide-induced apoptosis in human pancreatic carcinoma cell lines is associated with a G1-arrest and an increase of the cyclin-dependent kinase inhibitor p21WAF1\/CIP1. Cell Growth Differ 9:611\u2013617","journal-title":"Cell Growth Differ"},{"key":"9402_CR34","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1006\/cimm.2000.1682","volume":"203","author":"JY Kwak","year":"2000","unstructured":"Kwak JY, Han MK, Choi KS et al (2000) Cytokines secreted by lymphokine-activated killer cells induce endogenous nitric oxide synthesis and apoptosis in DLD-1 colon cancer cells. Cell Immunol 203:84\u201394","journal-title":"Cell Immunol"},{"key":"9402_CR35","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s10555-006-9004-4","volume":"25","author":"RN Apte","year":"2006","unstructured":"Apte RN, Dotan S, Elkabets M et al (2006) The involvement of IL-1 in tumorigenesis tumor invasiveness metastasis and tumor\u2013host interactions. Cancer Metastasis Rev 25:387\u2013408","journal-title":"Cancer Metastasis Rev"},{"key":"9402_CR36","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1073\/pnas.0437939100","volume":"100","author":"E Voronov","year":"2003","unstructured":"Voronov E, Shouval DS, Krelin Y et al (2003) IL-1 is required for tumor invasiveness and angiogenesis. Proc Natl Acad Sci USA 100:2645\u20132650","journal-title":"Proc Natl Acad Sci USA"},{"key":"9402_CR37","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1006\/bbrc.1996.1471","volume":"227","author":"G Paravicini","year":"1996","unstructured":"Paravicini G, Steinmayr M, Andre E et al (1996) The metastasis suppressor candidate nucleotide diphosphate kinase NM23 specifically interacts with members of the ROR\/RZR nuclear orphan receptor subfamily. Biochem Biophys Res Commun 227:82\u201387","journal-title":"Biochem Biophys Res Commun"},{"key":"9402_CR38","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2174\/156800909787314002","volume":"9","author":"S Ulisse","year":"2009","unstructured":"Ulisse S, Baldini E, Sorrenti S et al (2009) The urokinase plasminogen activator system: a target for anti-cancer therapy. Curr Cancer Drug Targets 9:32\u201371","journal-title":"Curr Cancer Drug Targets"},{"key":"9402_CR39","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1593\/neo.10296","volume":"12","author":"SA Rabbani","year":"2010","unstructured":"Rabbani SA, Ateeq B, Arakelian A et al (2010) An anti-urokinase plasminogen activator receptor antibody (ATN-658) blocks prostate cancer invasion migration growth and experimental skeletal metastasis in vitro and in vivo. Neoplasia 12:778\u2013788","journal-title":"Neoplasia"},{"key":"9402_CR40","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.oraloncology.2008.03.004","volume":"44","author":"X Liang","year":"2008","unstructured":"Liang X, Yang X, Tang Y et al (2008) RNAi-mediated downregulation of urokinase plasminogen activator receptor inhibits proliferation adhesion migration and invasion in oral cancer cells. Oral Oncol 44:1172\u20131180","journal-title":"Oral Oncol"},{"key":"9402_CR41","first-page":"929","volume":"33","author":"K Yoneda","year":"2008","unstructured":"Yoneda K, Sugimoto K, Shiraki K et al (2008) Dual topology of functional Toll-like receptor 3 expression in human hepatocellular carcinoma: differential signaling mechanisms of TLR3-induced NF-kappaB activation and apoptosis. Int J Oncol 33:929\u2013936","journal-title":"Int J Oncol"},{"key":"9402_CR42","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1002\/jcb.21119","volume":"100","author":"E Khvalevsky","year":"2007","unstructured":"Khvalevsky E, Rivkin L, Rachmilewitz J et al (2007) TLR3 signaling in a hepatoma cell line is skewed towards apoptosis. J Cell Biochem 100:1301\u20131312","journal-title":"J Cell Biochem"},{"key":"9402_CR43","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1210\/en.2007-0459","volume":"148","author":"KD McCall","year":"2007","unstructured":"McCall KD, Harii N, Lewis CJ et al (2007) High basal levels of functional toll-like receptor 3 (TLR3) and noncanonical Wnt5a are expressed in papillary thyroid cancer and are coordinately decreased by phenylmethimazole together with cell proliferation and migration. Endocrinology 148:4226\u20134237","journal-title":"Endocrinology"},{"key":"9402_CR44","doi-asserted-by":"crossref","first-page":"4114","DOI":"10.1158\/1078-0432.CCR-09-0005","volume":"15","author":"AL Schwartz","year":"2009","unstructured":"Schwartz AL, Malgor R, Dickerson E et al (2009) Phenylmethimazole decreases Toll-like receptor 3 and noncanonical Wnt5a expression in pancreatic cancer and melanoma together with tumor cell growth and migration. Clin Cancer Res 15:4114\u20134122","journal-title":"Clin Cancer Res"},{"key":"9402_CR45","doi-asserted-by":"crossref","first-page":"29485","DOI":"10.1074\/jbc.M801269200","volume":"283","author":"KL Edelblum","year":"2008","unstructured":"Edelblum KL, Goettel JA, Koyama T et al (2008) TNFR1 promotes tumor necrosis factor-mediated mouse colon epithelial cell survival through RAF activation of NF-kappaB. J Biol Chem 283:29485\u201329494","journal-title":"J Biol Chem"},{"key":"9402_CR46","doi-asserted-by":"crossref","first-page":"13245","DOI":"10.1074\/jbc.273.21.13245","volume":"273","author":"SK Manna","year":"1998","unstructured":"Manna SK, Zhang HJ, Yan T et al (1998) Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappaB and activated protein-1. J Biol Chem 273:13245\u201313254","journal-title":"J Biol Chem"},{"key":"9402_CR47","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.1038\/sj.onc.1202811","volume":"18","author":"SK Manna","year":"1999","unstructured":"Manna SK, Kuo MT, Aggarwal BB (1999) Overexpression of gamma-glutamylcysteine synthetase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappa B and activator protein-1. Oncogene 18:4371\u20134382","journal-title":"Oncogene"},{"key":"9402_CR48","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1593\/neo.92106","volume":"12","author":"A Paone","year":"2010","unstructured":"Paone A, Galli R, Gabellini C et al (2010) Toll-like receptor 3 regulates angiogenesis and apoptosis in prostate cancer cell lines through hypoxia-inducible factor 1 alpha. Neoplasia 12:539\u2013549","journal-title":"Neoplasia"},{"key":"9402_CR49","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0076-6879(07)35022-2","volume":"435","author":"A Gorlach","year":"2007","unstructured":"Gorlach A, Kietzmann T (2007) Superoxide and derived reactive oxygen species in the regulation of hypoxia-inducible factors. Methods Enzymol 435:421\u2013446","journal-title":"Methods Enzymol"}],"container-title":["Clinical &amp; Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-011-9402-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10585-011-9402-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-011-9402-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T16:02:53Z","timestamp":1560355373000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10585-011-9402-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,7]]},"references-count":49,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["9402"],"URL":"https:\/\/doi.org\/10.1007\/s10585-011-9402-z","relation":{},"ISSN":["0262-0898","1573-7276"],"issn-type":[{"value":"0262-0898","type":"print"},{"value":"1573-7276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,7]]}}}